"Iron Chelating Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Organic chemicals that form two or more coordination links with an iron ion. Once coordination has occurred, the complex formed is called a chelate. The iron-binding porphyrin group of hemoglobin is an example of a metal chelate found in biological systems.
Descriptor ID |
D007502
|
MeSH Number(s) |
D27.505.519.914.500.410 D27.720.832.500.410
|
Concept/Terms |
Iron Chelating Agents- Iron Chelating Agents
- Agents, Iron Chelating
- Chelating Agents, Iron
- Iron Chelates
- Chelates, Iron
|
Below are MeSH descriptors whose meaning is more general than "Iron Chelating Agents".
Below are MeSH descriptors whose meaning is more specific than "Iron Chelating Agents".
This graph shows the total number of publications written about "Iron Chelating Agents" by people in this website by year, and whether "Iron Chelating Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2004 | 0 | 1 | 1 |
2005 | 1 | 0 | 1 |
2015 | 1 | 0 | 1 |
2016 | 1 | 0 | 1 |
2017 | 7 | 4 | 11 |
2018 | 2 | 4 | 6 |
2019 | 4 | 1 | 5 |
2020 | 3 | 1 | 4 |
2021 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Iron Chelating Agents" by people in Profiles.
-
Deferoxamine B: A Natural, Excellent and Versatile Metal Chelator. Molecules. 2021 May 28; 26(11).
-
SARS-CoV-2 infection in patients with ß-thalassemia: Experience from Lebanon. Am J Hematol. 2021 08 01; 96(8):E285-E288.
-
Off-label tocilizumab and adjuvant iron chelator effectiveness in a group of severe COVID-19 pneumonia patients: A single center experience. Medicine (Baltimore). 2021 May 07; 100(18):e25832.
-
SARS-CoV-2 Mediated Hyperferritinemia and Cardiac Arrest: Preliminary Insights. Drug Discov Today. 2021 05; 26(5):1265-1274.
-
Complement activation and coagulopathy - an ominous duo in COVID19. Expert Rev Hematol. 2021 02; 14(2):155-173.
-
The role of iron in the pathogenesis of COVID-19 and possible treatment with lactoferrin and other iron chelators. Biomed Pharmacother. 2021 Apr; 136:111228.
-
What Can Cellular Redox, Iron, and Reactive Oxygen Species Suggest About the Mechanisms and Potential Therapy of COVID-19? Front Cell Infect Microbiol. 2020; 10:569709.
-
Hyperferritinemia in patients with COVID-19: An opportunity for iron chelation? Artif Organs. 2021 Feb; 45(2):163-167.
-
Iron chelation may harm patients with COVID-19. Eur J Clin Pharmacol. 2021 02; 77(2):265-266.
-
Reply: Iron chelation may harm patients with COVID-19. Eur J Clin Pharmacol. 2021 02; 77(2):267-268.